For patients with metastatic thymic carcinoma, is there a role for local treatment options such as SBRT for oligoprogressive or oligopersistent disease after systemic therapy?  

Of course, there is no data on this question for people with thymic carcinoma. Metastatic thymic carcinoma is generally treated with systemic therapy which is guided to some extent by the histologic subtype of the tumor. Most commonly, we would utilize a regimen such as CAP (cyclophosphamide, doxoru...